Stabilization of protein-protein interaction complexes through small molecules

Drug Discovery Today

Volumn 21, Issue 1, 2016, Pages 48-57

  Zarzycka, Barbara ^a   Kuenemann, Mélaine A ^b,c   Miteva, Maria A ^b,c   Nicolaes, Gerry A F ^a   Vriend, Gert ^e   Sperandio, Olivier ^b,c,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d UNIV LILLE   (France)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL BINDING; CLASSIFICATION; PROTEIN PROTEIN INTERACTION; BIOPHYSICS; DRUG EFFECTS; HUMAN; MOLECULAR LIBRARY; PHARMACOLOGY;

MOLECULAR LIBRARY; PROTEIN BINDING;

BIOPHYSICAL PHENOMENA; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; SMALL MOLECULE LIBRARIES;

EID: 84960331999     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.09.011     Document Type: Review

References (80)

1. K. Venkatesan, and et al. An empirical framework for binary interactome mapping Nat. Methods 6 2009 83 90
2. X. Morelli, and et al. Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I) Curr. Opin. Chem. Biol. 15 2011 475 481
3. C.M. Labbé, and et al. iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions Drug Discov. Today 18 2013 958 968
4. A.P. Higueruelo, and et al. TIMBAL v2: update of a database holding small molecules modulating protein-protein interactions Database (Oxford) 2013, bat039 2013
5. P. Thiel, and et al. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery? Angew. Chem. Int. Ed. Engl. 51 2012 2012 2018
6. L.B. Sheard, and et al. Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor Nature 468 2010 400 405
7. P. Block, and et al. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study Proteins 68 2007 170 186
8. F. Giordanetto, and et al. Stabilization of protein-protein interactions by small molecules Drug Discov. Today 19 2014 1812 1821
9. J. Monod, and et al. On the nature of allosteric transitions: a plausible model J. Mol. Biol. 12 1965 88 118
10. D.S. Goodsell, and A.J. Olson Structural symmetry and protein function Annu. Rev. Biophys. Biomol. Struct. 29 2000 105 153
11. I.M.A. Nooren, and J.M. Thornton Diversity of protein-protein interactions EMBO J. 22 2003 3486 3492
12. H. Hermeking, and A. Benzinger 14-3-3 proteins in cell cycle regulation Semin. Cancer Biol. 16 2006 183 192
13. M. Piotrowski, and et al. Complementation of the Saccharomyces cerevisiae plasma membrane H+-ATPase by a plant H+-ATPase generates a highly abundant fusicoccin binding site J. Biol. Chem. 273 1998 30018 30023
14. C. Ottmann, and et al. A structural rationale for selective stabilization of anti-tumor interactions of 14-3-3 proteins by cotylenin A J. Mol. Biol. 386 2009 913 919
15. R. Rose, and et al. Identification and structure of small-molecule stabilizers of 14-3-3 protein-protein interactions Angew. Chem. Int. Ed Engl. 49 2010 4129 4132
16. A. Richter, and et al. An optimised small-molecule stabiliser of the 14-3-3-PMA2 protein-protein interaction Chem. Weinh. Bergstr. Ger. 18 2012 6520 6527
17. M. Molzan, and et al. Stabilization of physical RAF/14-3-3 interaction by cotylenin A as treatment strategy for RAS mutant cancers ACS Chem. Biol. 8 2013 1869 1875
18. I.J. De Vries-van Leeuwen, and et al. Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface Proc. Natl. Acad. Sci. U. S. A. 110 2013 8894 8899
19. C. Anders, and et al. A semisynthetic fusicoccane stabilizes a protein-protein interaction and enhances the expression of K+ channels at the cell surface Chem. Biol. 20 2013 583 593
20. M. Zuzarte, and et al. Intracellular traffic of the K+ channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins J. Physiol. 587 2009 929 952
21. G. Nalepa, and et al. Drug discovery in the ubiquitin-proteasome system Nat. Rev. Drug Discov. 5 2006 596 613
22. D.F. Ceccarelli, and et al. An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme Cell 145 2011 1075 1087
23. H. Huang, and et al. E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin Nat. Chem. Biol. 10 2014 156 163
24. S. Frank, and et al. ARNO is a guanine nucleotide exchange factor for ADP-ribosylation factor 6 J. Biol. Chem. 273 1998 23 27
25. C. D'Souza-Schorey, and P. Chavrier ARF proteins: roles in membrane traffic and beyond Nat. Rev. Mol. Cell Biol. 7 2006 347 358
26. J. Viaud, and et al. Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes Proc. Natl. Acad. Sci. U. S. A. 104 2007 10370 10375
27. Y.D. Wen, and et al. The histone deacetylase-3 complex contains nuclear receptor corepressors Proc. Natl. Acad. Sci. U. S. A. 97 2000 7202 7207
28. P.J. Watson, and et al. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate Nature 481 2012 335 340
29. P.J. Davies The plant hormones: their nature, occurrence and functions 2009 10.1007/978-1-4020-2686-7-1
30. X. Tan, and et al. Mechanism of auxin perception by the TIR1 ubiquitin ligase Nature 446 2007 640 645
31. J. Santiago, and et al. Molecular mechanism for plant steroid receptor activation by somatic embryogenesis co-receptor kinases Science 341 2013 889 892
32. J.P. Adelman, and et al. Small-conductance Ca2+-activated K+ channels: form and function Annu. Rev. Physiol. 74 2012 245 269
33. P.T. Ellinor, and et al. Common variants in KCNN3 are associated with lone atrial fibrillation Nat. Genet. 42 2010 240 244
34. E.S.L. Faber, and P. Sah Functions of SK channels in central neurons Clin. Exp. Pharmacol. Physiol. 34 2007 1077 1083
35. 2+-activated potassium channels Nat. Commun. 3 2012 1021
36. 2+-sensing and SK channel activation Proc. Natl. Acad. Sci. U. S. A. 110 2013 4828 4833
37. S. Fukuda, and L.M. Pelus Survivin, a cancer target with an emerging role in normal adult tissues Mol. Cancer Ther. 5 2006 1087 1098
38. S.N. Chettiar, and et al. Design, synthesis and biological studies of survivin dimerization modulators that prolong mitotic cycle Bioorg. Med. Chem. Lett. 23 2013 5429 5433
39. M.D. Wendt, and et al. Discovery of a novel small molecule binding site of human survivin Bioorg. Med. Chem. Lett. 17 2007 3122 3129
40. J. Roca, and J.C. Wang The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases Cell 71 1992 833 840
41. G. Weiss, and et al. Dexrazoxane (ICRF-187) Gen. Pharmacol. 32 1999 155 158
42. B.B. Hasinoff, and et al. A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane) Biochem. Pharmacol. 50 1995 953 958
43. S. Classen, and et al. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187 Proc. Natl. Acad. Sci. U. S. A. 100 2003 10629 10634
44. H.L. Monaco, and et al. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein Science 268 1995 1039 1041
45. J.C. Sacchettini, and J.W. Kelly Therapeutic strategies for human amyloid diseases Nat. Rev. Drug Discov. 1 2002 267 275
46. C.E. Bulawa, and et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade Proc. Natl. Acad. Sci. U. S. A. 109 2012 9629 9634
47. S. Chenavas, and et al. Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target Future Microbiol. 8 2013 1537 1545
48. S.W. Gerritz, and et al. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers Proc. Natl. Acad. Sci. U. S. A. 108 2011 15366 15371
49. M. Wade, and G.M. Wahl Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry? Mol. Cancer Res. 7 2009 1 11
50. B. Graves, and et al. Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization Proc. Natl. Acad. Sci. U. S. A. 109 2012 11788 11793
51. T. Berg Small-molecule modulators of c-Myc/Max and Max/Max interactions Curr. Top. Microbiol. Immunol. 348 2011 139 149
52. A. Kiessling, and et al. Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules Chem. Biol. 13 2006 745 751
53. H. Jiang, and et al. Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function Mol. Pharmacol. 76 2009 491 502
54. Z. Kelman PCNA: structure, functions and interactions Oncogene 14 1997 629 640
55. Z. Tan, and et al. Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth Mol. Pharmacol. 81 2012 811 819
56. G. Kontopidis, and et al. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design Proc. Natl. Acad. Sci. U. S. A. 102 2005 1871 1876
57. M. Schneider, and et al. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? J. Mol. Med. Berl. Ger. 86 2008 507 522
58. V.N. Malashkevich, and et al. Phenothiazines inhibit S100A4 function by inducing protein oligomerization Proc. Natl. Acad. Sci. U. S. A. 107 2010 8605 8610
59. S.C. Garrett, and et al. A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics Biochemistry 47 2008 986 996
60. M.A. Palladino, and et al. Anti-TNF-alpha therapies: the next generation Nat. Rev. Drug Discov. 2 2003 736 746
61. M.M. He, and et al. Small-molecule inhibition of TNF-alpha Science 310 2005 1022 1025
62. U. Schönbeck, and P. Libby The CD40/CD154 receptor/ligand dyad Cell. Mol. Life Sci. 58 2001 4 43
63. L.F. Silvian, and et al. Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism ACS Chem. Biol. 6 2011 636 647
64. R.F. Ludueńa, and et al. Structure of the tubulin dimer J. Biol. Chem. 252 1977 7006 7014
65. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat. Rev. Cancer 4 2004 253 265
66. G.M. Alushin, and et al. High-resolution microtubule structures reveal the structural transitions in αβ-tubulin upon GTP hydrolysis Cell 157 2014 1117 1129
67. R.H. Brown Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice Cell 80 1995 687 692
68. S.S. Ray, and et al. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation Proc. Natl. Acad. Sci. U. S. A. 102 2005 3639 3644
69. G.S.A. Wright, and et al. Ligand binding and aggregation of pathogenic SOD1 Nat. Commun. 4 2013 1758
70. D.J. Mangelsdorf, and et al. The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
71. A. Le Maire, and et al. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor Nat. Struct. Mol. Biol. 17 2010 801 807
72. H. Gronemeyer, and et al. Principles for modulation of the nuclear receptor superfamily Nat. Rev. Drug Discov. 3 2004 950 964
73. J.J. Siekierka, and et al. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin Nature 341 1989 755 757
74. J. Leandro, and et al. The G46S-hPAH mutant protein: a model to study the rescue of aggregation-prone PKU mutations by chaperones Mol. Genet. Metab. 104 Suppl. 2011 40 44
75. C. Ottmann, and et al. Structure of a 14-3-3 coordinated hexamer of the plant plasma membrane H+-ATPase by combining X-ray crystallography and electron cryomicroscopy Mol. Cell 25 2007 427 440
76. M. Würtele, and et al. Structural view of a fungal toxin acting on a 14-3-3 regulatory complex EMBO J. 22 2003 987 994
77. +-channel activity 2011
78. L. Renault, and et al. Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor Nature 426 2003 525 530
79. N. Dharmasiri, and et al. The F-box protein TIR1 is an auxin receptor Nature 435 2005 441 445
80. Z.Y. Wang, and et al. BRI1 is a critical component of a plasma-membrane receptor for plant steroids Nature 410 2001 380 383